Ann Marie Navar, MD, PhD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt St., Box 3850, Durham, NC 27705
Phone (919) 684-8111

Education and Training

  • Cardiovascular Disease Fellowship, Duke University School of Medicine, 2013 - 2016
  • Internal Medicine and Pediatrics Residency, Duke University School of Medicine, 2009 - 2013
  • Ph.D., Johns Hopkins University, 2009
  • M.D., Duke University School of Medicine, 2009
  • M.H.S., Johns Hopkins University, 2005

Publications

Vaduganathan, M, Nagarur, A, Qamar, A, Patel, RB, Navar, AM, Peterson, ED, Bhatt, DL, Fonarow, GC, Yancy, CW, and Butler, J. "Availability and Use of Shared Data From Cardiometabolic Clinical Trials." Circulation 137, no. 9 (February 2018): 938-947.

PMID
29133600
Full Text

Griffin, A, Navar, AM, Crawford, L, Mammarappallil, J, and Koweek, LH. "A case of spontaneous coronary artery dissection diagnosed by coronary computed tomography angiography." Journal of cardiovascular computed tomography 12, no. 1 (January 2018): 88-89.

PMID
28935520
Full Text

Hess, PL, Kennedy, K, Cowherd, M, Virani, SS, Masoudi, FA, Navar, AM, Yeh, RW, Ho, PM, and Maddox, TM. "Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project." American heart journal 195 (January 2018): 151-152. (Letter)

PMID
29224643
Full Text

Navar, AM, Gallup, DS, Lokhnygina, Y, Green, JB, McGuire, DK, Armstrong, PW, Buse, JB, Engel, SS, Lachin, JM, Standl, E, Van de Werf, F, Holman, RR, Peterson, ED, and TECOS Study Group, . "Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin." Hypertension (Dallas, Tex. : 1979) 70, no. 5 (November 2017): 907-914.

PMID
28847886
Full Text

Navar, AM, Taylor, B, Mulder, H, Fievitz, E, Monda, KL, Fievitz, A, Maya, JF, López, JAG, and Peterson, ED. "Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy." JAMA cardiology 2, no. 11 (November 2017): 1217-1225.

PMID
28973087
Full Text

Navar, AM, Wang, TY, Li, S, Robinson, JG, Goldberg, AC, Virani, S, Roger, VL, Wilson, PWF, Elassal, J, Lee, LV, and Peterson, ED. "Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry." American heart journal 193 (November 2017): 84-92.

PMID
29129260
Full Text

Fanaroff, AC, Roe, MT, Clare, RM, Lokhnygina, Y, Navar, AM, Giugliano, RP, Wiviott, SD, Tershakovec, AM, Braunwald, E, and Blazing, MA. "Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes." Journal of the American Heart Association 6, no. 9 (September 18, 2017).

PMID
28923989
Full Text

Pagidipati, NJ, Navar, AM, Pieper, KS, Green, JB, Bethel, MA, Armstrong, PW, Josse, RG, McGuire, DK, Lokhnygina, Y, Cornel, JH, Halvorsen, S, Strandberg, TE, Delibasi, T, Holman, RR, Peterson, ED, and TECOS Study Group, . "Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)." Circulation 136, no. 13 (September 2017): 1193-1203.

PMID
28626088
Full Text

Pagidipati, NJ, Navar, AM, and Pencina, MJ. "Guideline Recommendations for Statin Therapy-Reply." JAMA 318, no. 10 (September 2017): 964-. (Letter)

PMID
28898376
Full Text

Peterson, ED, and Navar, AM. ""Sticky" Issues for Adherence in Secondary Prevention." Journal of the American College of Cardiology 70, no. 13 (September 2017): 1555-1557.

PMID
28935031
Full Text

Pages